Therapeutics News

Arcutis reported its financial results for the third quarter of 2023, which included a total revenue of $38.1 million and a 70% increase in Zoryve revenue, according to a company press release.

While certain demographic factors were associated with a higher risk for paradoxical eczema among patients with psoriasis, treatment with certain biologic classes was not, according to a study.

Isotretinoin is not associated with an increased risk for suicide or psychiatric conditions on a population level, according to a study.

Almirall has entered a collaboration with the Barcelona Supercomputing Center and Nostrum Biodiscovery to research the use of artificial intelligence in dermatological therapies, the companies announced in a joint press release.

The top 10 most viewed YouTube videos about topical corticosteroid withdrawal reflect poor reliability and accuracy, according to a study.

The annual American Society for Dermatologic Surgery meeting was recently held in Chicago, bringing together a wide variety of clinical knowledge, techniques and news.

Terbinafine dosed daily and continuously for the treatment of onychomycosis in patients with skin of color may produce better outcomes than intermittent terbinafine, according to a study.

Patients with onychomycosis experience low treatment rates with treatments being prescribed in 20% of all visits for this condition, according to a study.

Each year, WHO marks World Mental Health Day on Oct. 10 in an effort to raise awareness of mental health issues around the world and mobilize efforts to support mental health.

NEW YORK — In this Healio video exclusive, Andrew F. Alexis, MD, MPH, cofounder and cochair of the Skin of Color Update 2023 meeting, highlights the importance, progress and future of dermatological care for patients with skin of color.